glucagon has been researched along with Hyperlipoproteinemias in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heinke, P; Ratzmann, KP; Schulz, B; Witt, S; Ziegler, M | 1 |
| Ratzmann, KP | 1 |
| Efendic, S; Gutniak, M; Hamsten, A; Juntti-Berggren, L; Karpe, F; Pigon, J; Vignati, L | 1 |
1 trial(s) available for glucagon and Hyperlipoproteinemias
| Article | Year |
|---|---|
The antidiabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinemia in NIDDM patients.
Topics: Blood Glucose; C-Peptide; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hyperlipoproteinemias; Hypoglycemic Agents; Insulin; Lipoproteins, VLDL; Male; Middle Aged; Peptide Fragments; Protein Precursors; Time Factors; Triglycerides | 1996 |
2 other study(ies) available for glucagon and Hyperlipoproteinemias
| Article | Year |
|---|---|
Pancreatic glucagon response to glucose in hyperlipoproteinaemia with and without abnormalities in carbohydrate metabolism.
Topics: Adult; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Humans; Hyperlipoproteinemias; Insulin; Insulin Secretion; Male; Obesity | 1980 |
[Glucagon secretion in hyperlipoproteinemia and adiposity].
Topics: Animals; Glucagon; Glucose Tolerance Test; Humans; Hyperlipoproteinemias; Obesity; Rats | 1982 |